Ms Ina Margaretha Rijnhout is President of Lamina.
With over 20 years international experience in building and expanding life science companies on a global scale, Ina has been responsible for general management, R&D, business development, licensing and strategic partnering. Ina combines knowledge of the (bio)pharmaceutical R&D industry, life science start-ups and investment community with clinical and commercial experience in large pharma and service industry. She has special affinity with regenerative medicine, developing therapies for patients in need with disorders for which currently no treatment exists. Ina has a MSc Medical Sciences, from Leiden Medical University, The Netherlands